3/12
07:49 am
ints
Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study [Yahoo! Finance]
Medium
Report
Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study [Yahoo! Finance]
3/12
07:30 am
ints
Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study
Medium
Report
Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study
3/6
08:05 am
ints
Intensity Therapeutics regains compliance with Nasdaq's minimum bid price requirement [Seeking Alpha]
Low
Report
Intensity Therapeutics regains compliance with Nasdaq's minimum bid price requirement [Seeking Alpha]
3/6
08:02 am
ints
Intensity Therapeutics Regains Compliance with Nasdaq's Minimum Bid Price Requirement [Yahoo! Finance]
Neutral
Report
Intensity Therapeutics Regains Compliance with Nasdaq's Minimum Bid Price Requirement [Yahoo! Finance]
3/6
07:47 am
ints
Intensity Therapeutics Regains Compliance with Nasdaq's Minimum Bid Price Requirement
Low
Report
Intensity Therapeutics Regains Compliance with Nasdaq's Minimum Bid Price Requirement
2/13
08:58 am
ints
Intensity Therapeutics Announces Reverse Stock Split
High
Report
Intensity Therapeutics Announces Reverse Stock Split
1/13
07:47 am
ints
Intensity Therapeutics Highlights 2025 Milestones and Outlines 2026 Strategic Priorities
Low
Report
Intensity Therapeutics Highlights 2025 Milestones and Outlines 2026 Strategic Priorities